Ian Peikon

Title: The Innovative Contributions of Ian Peikon

Introduction

Ian Peikon is a notable inventor based in Bethpage, NY (US), recognized for his significant contributions to the field of proteomics and gene editing. With a total of eight patents to his name, Peikon has made strides in developing methods and compositions that enhance our understanding of cellular processes.

Latest Patents

Among his latest patents is the invention titled "Quantitative Massively Parallel Proteomics." This patent provides compositions and methods for identifying expression profiles in single cells or populations of cells. It also includes kits that feature antibodies with unique molecular identifiers and primers for amplification of the antibody identifier sequence. Another significant patent is "Endogenous Gag-Based Capsids and Uses Thereof." This invention involves isolating nucleic acids encoding endogenous Gag peptides from various organisms, including human DNA. These nucleic acids can be utilized to express endogenous Gag polypeptides that assemble into capsids, which can package and deliver nucleic acid molecules for gene editing applications, such as those involved in the CRISPR-Cas system.

Career Highlights

Throughout his career, Ian Peikon has worked with prominent companies, including Verily Life Sciences LLC and VNV Newco Inc. His work in these organizations has allowed him to apply his innovative ideas and contribute to advancements in biotechnology.

Collaborations

Ian has collaborated with talented individuals in his field, including Gary Tong and Colin Malone. These partnerships have fostered an environment of creativity and innovation, leading to the development of groundbreaking technologies.

Conclusion

Ian Peikon's contributions to the fields of proteomics and gene editing exemplify the impact of innovative thinking in science and technology. His patents and collaborations continue to influence advancements in these critical areas.